{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "03", "@year": "2024", "@timestamp": "2024-11-03T01:44:53.000053-05:00", "@month": "11"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "12"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Siam Pharmaceutical Co., Ltd."}, {"xocs:funding-agency-matched-string": "Faculty of Medicine, Prince of Songkla University", "xocs:funding-agency": "Faculty of Medicine, Prince of Songkla University", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100010804", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}], "xocs:funding-addon-generated-timestamp": "2021-06-04T04:46:43.928Z", "xocs:funding-text": "Sulbactam (Sibatam) was donated by the Siam Pharmaceutical Co., Ltd. (Bangkok, Thailand). We thank David Patterson for proofreading the manuscript and Robert J. Bauer (Vice President, Pharmacometrics RandD, ICON Early Phase) for population PK analysis. This work was supported by a grant from the Faculty of Medicine, Prince of Songkla University. We declare that we have no conflicts of interest related to this work.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "@afid": "60006314", "@country": "tha", "city": "Hat Yai, Songkla", "organization": [{"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Prince of Songkla University"}], "affiliation-id": {"@afid": "60006314", "@dptid": "103359862"}, "@dptid": "103359862"}, "author": [{"ce:given-name": "Sutep", "preferred-name": {"ce:given-name": "Sutep", "ce:initials": "S.", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Jaruratanasirikul", "@auid": "57208302098", "ce:indexed-name": "Jaruratanasirikul S."}, {"ce:given-name": "Maseetoh", "preferred-name": {"ce:given-name": "Maseetoh", "ce:initials": "M.", "ce:surname": "Samaeng", "ce:indexed-name": "Samaeng M."}, "@seq": "5", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Samaeng", "@auid": "37064896200", "ce:indexed-name": "Samaeng M."}, {"ce:given-name": "Monchana", "preferred-name": {"ce:given-name": "Monchana", "ce:initials": "M.", "ce:surname": "Nawakitrangsan", "ce:indexed-name": "Nawakitrangsan M."}, "@seq": "6", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Nawakitrangsan", "@auid": "57191380618", "ce:indexed-name": "Nawakitrangsan M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60006314", "@country": "tha", "city": "Hat Yai, Songkla", "organization": [{"$": "Department of Pharmaceutical Technology"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Prince of Songkla University"}], "affiliation-id": {"@afid": "60006314", "@dptid": "112890853"}, "@dptid": "112890853"}, "author": [{"ce:given-name": "Wibul", "preferred-name": {"ce:given-name": "Wibul", "ce:initials": "W.", "ce:surname": "Wongpoowarak", "ce:indexed-name": "Wongpoowarak W."}, "@seq": "2", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Wongpoowarak", "@auid": "6603470219", "ce:indexed-name": "Wongpoowarak W."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Pathumwan", "organization": [{"$": "Department of Pharmacy Practice"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113044315"}, "state": "Bangkok", "@dptid": "113044315"}, "author": [{"ce:given-name": "Thitima", "preferred-name": {"ce:given-name": "Thitima", "ce:initials": "T.", "ce:surname": "Wattanavijitkul", "ce:indexed-name": "Wattanavijitkul T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Wattanavijitkul", "@auid": "56422407400", "ce:indexed-name": "Wattanavijitkul T."}, {"ce:given-name": "Waroonrat", "preferred-name": {"ce:given-name": "Waroonrat", "ce:initials": "W.", "ce:surname": "Sukarnjanaset", "ce:indexed-name": "Sukarnjanaset W."}, "@seq": "4", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Sukarnjanaset", "@auid": "56652241200", "ce:indexed-name": "Sukarnjanaset W."}]}, {"affiliation": {"country": "Thailand", "@afid": "60006314", "@country": "tha", "city": "Hat Yai, Songkla", "organization": [{"$": "Department of Pathology"}, {"$": "Faculty of Medicine"}, {"$": "Prince of Songkla University"}], "affiliation-id": {"@afid": "60006314", "@dptid": "103359866"}, "@dptid": "103359866"}, "author": [{"ce:given-name": "Natnicha", "preferred-name": {"ce:given-name": "Natnicha", "ce:initials": "N.", "ce:surname": "Ingviya", "ce:indexed-name": "Ingviya N."}, "@seq": "7", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Ingviya", "@auid": "8708620300", "ce:indexed-name": "Ingviya N."}]}], "citation-title": "Population pharmacokinetics and pharmacodynamics modeling to optimize dosage regimens of sulbactam in critically ill patients with severe sepsis caused by Acinetobacter baumannii", "abstracts": "Copyright \u00a9 2016, American Society for Microbiology. All Rights Reserved.Sulbactam is being considered as an alternative concomitant medication with other effective antibiotics for the treatment of multidrug-resistant (MDR) Acinetobacter baumannii infections. Pathophysiological changes in critically ill patients with severe sepsis, resulting in altered pharmacokinetic (PK) patterns for antibiotics, are important factors in determining therapeutic success. The aims of this study were (i) to examine the population PK parameters and (ii) to assess the probability of target attainment (PTA) for sulbactam in patients with severe sepsis caused by A. baumannii. PK studies were carried out following administration of 2 g of sulbactam every 12 h on the 4th day of drug administration in 27 patients, and a Monte Carlo simulation was performed to determine the PTA of achieving 40% exposure time during which the plasma drug concentration remained above the MIC (T>MIC) and 60% T>MIC. The central and peripheral volumes of distribution were 14.56 and 9.55 liters, respectively, and total clearances of sulbactam were 2.26 liters/h and 7.64 liters/h in patients aged >65 years and \u226465 years, respectively. The high PTAs (\u226590%) for targets of 40% T>MIC and 60% T>MIC with a MIC of 4 \u03bcg/ml were observed when sulbactam was administered by a 4-h infusion of 1 g every 12 h and 1 g every 8 h, respectively. Sulbactam would be an alternative antibiotic option to coadminister with colistin for the treatment of infections caused by MDR A. baumannii. However, for pathogens with MICs of >4 \u03bcg/ml, higher dosage regimens of sulbactam are required.", "correspondence": {"affiliation": {"country": "Thailand", "@country": "tha", "city": "Hat Yai, Songkla", "organization": [{"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Prince of Songkla University"}]}, "person": {"ce:given-name": "Sutep", "ce:initials": "S.", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}}, "citation-info": {"citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://aac.asm.org/content/60/12/7236.full.pdf+html", "@type": "email"}}, "translated-sourcetitle": {"$": "Antimicrobial Agents and Chemotherapy", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "60", "@issue": "12"}, "pagerange": {"@first": "7236", "@last": "7244"}}, "@type": "j", "sourcetitle": "Antimicrobial Agents and Chemotherapy", "publicationdate": {"month": "12", "year": "2016", "date-text": "December 2016", "day": "01"}, "codencode": "AMACC", "sourcetitle-abbrev": "Antimicrob. Agents Chemother.", "@country": "usa", "issn": [{"$": "10986596", "@type": "electronic"}, {"$": "00664804", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "American Society for Microbiology", "ce:e-address": {"$": "Journals@asmusa.org", "@type": "email"}}, "@srcid": "19615"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "17", "classification-description": "Public Health, Social Medicine and Epidemiology"}, {"classification-code": "24", "classification-description": "Anesthesiology"}, {"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "5", "classification-description": "General Pathology and Pathological Anatomy"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "2736"}, {"$": "2725"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "tradenamegroup": {"tradenames": {"trademanuitem": {"tradename": "sibatam", "manufacturer": {"@country": "tha", "$": "Siam"}}, "@type": "TNM"}}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": [{"$": "1066-17-7"}, {"$": "1264-72-8"}], "chemical-name": "colistin"}, {"cas-registry-number": "68373-14-8", "chemical-name": "sulbactam"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Anti-Bacterial Agents"}, {"chemical-name": "Colistin"}, {"chemical-name": "Sulbactam"}]}]}, "manufacturergroup": {"manufacturers": {"@type": "MNF", "manufacturer": [{"@country": "tha", "$": "Siam"}, "US Pharmacopeial Convention"]}}}, "grantlist": {"@complete": "y", "grant-text": {"$": "Sulbactam (Sibatam) was donated by the Siam Pharmaceutical Co., Ltd. (Bangkok, Thailand). We thank David Patterson for proofreading the manuscript and Robert J. Bauer (Vice President, Pharmacometrics RandD, ICON Early Phase) for population PK analysis. This work was supported by a grant from the Faculty of Medicine, Prince of Songkla University. We declare that we have no conflicts of interest related to this work.", "@xml:lang": "eng"}, "grant": {"grant-acronym": "PSU", "grant-agency": "Prince of Songkla University"}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CHEM"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "REAXYS"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "11", "@year": "2017", "@timestamp": "BST 06:46:39", "@month": "10"}}, "itemidlist": {"itemid": [{"$": "613337592", "@idtype": "PUI"}, {"$": "658377164", "@idtype": "CAR-ID"}, {"$": "2016226707", "@idtype": "CHEM"}, {"$": "20160862498", "@idtype": "EMBASE"}, {"$": "27671056", "@idtype": "MEDL"}, {"$": "2016294387", "@idtype": "REAXYS"}, {"$": "20162396726", "@idtype": "REAXYSCAR"}, {"$": "2016348770", "@idtype": "RMC"}, {"$": "84996567175", "@idtype": "SCP"}, {"$": "84996567175", "@idtype": "SGR"}, {"$": "618643946", "@idtype": "PUIsecondary"}], "ce:doi": "10.1128/AAC.01669-16"}}, "tail": {"bibliography": {"@refcount": "29", "reference": [{"ref-fulltext": "Cosgrove SE. 2006. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42(Suppl 2):S82-S89. http://dx.doi.org/10.1086/499406.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1086/499406", "@type": "email"}}, "ref-title": {"ref-titletext": "The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs"}, "refd-itemidlist": {"itemid": {"$": "30144435397", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "42"}, "pagerange": {"@first": "S82", "@last": "S89"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.E.", "@_fa": "true", "ce:surname": "Cosgrove", "ce:indexed-name": "Cosgrove S.E."}]}, "ref-sourcetitle": "Clin Infect Dis"}}, {"ref-fulltext": "Morata L, Cobos-Trigueros N, Mart\u00ednez JA, Soriano A, Almela M, Marco F, Sterzik H, N\u00fa\u00f1ez R, Hern\u00e1ndez C, Mensa J. 2012. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 56:4833-4837. http://dx.doi.org/10.1128/AAC.00750-12.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1128/AAC.00750-12", "@type": "email"}}, "ref-title": {"ref-titletext": "Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia"}, "refd-itemidlist": {"itemid": {"$": "84865432568", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "4833", "@last": "4837"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Morata", "ce:indexed-name": "Morata L."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Cobos-Trigueros", "ce:indexed-name": "Cobos-Trigueros N."}, {"@seq": "3", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Mart\u00ednez", "ce:indexed-name": "Martinez J.A."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Soriano", "ce:indexed-name": "Soriano A."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Almela", "ce:indexed-name": "Almela M."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Marco", "ce:indexed-name": "Marco F."}, {"@seq": "7", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Sterzik", "ce:indexed-name": "Sterzik H."}, {"@seq": "8", "ce:initials": "R.", "@_fa": "true", "ce:surname": "N\u00fa\u00f1ez", "ce:indexed-name": "Nunez R."}, {"@seq": "9", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Hern\u00e1ndez", "ce:indexed-name": "Hernandez C."}, {"@seq": "10", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Mensa", "ce:indexed-name": "Mensa J."}]}, "ref-sourcetitle": "Antimicrob Agents Chemother"}}, {"ref-fulltext": "Mahgoub S, Ahmed J, Glatt AE. 2002. Completely resistant Acinetobacter baumannii strains. Infect Control Hosp Epidemiol 23:477-479. http://dx.doi.org/10.1086/502091.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1086/502091", "@type": "email"}}, "ref-title": {"ref-titletext": "Completely resistant Acinetobacter baumannii strains"}, "refd-itemidlist": {"itemid": {"$": "0036677901", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "477", "@last": "479"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Mahgoub", "ce:indexed-name": "Mahgoub S."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ahmed", "ce:indexed-name": "Ahmed J."}, {"@seq": "3", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Glatt", "ce:indexed-name": "Glatt A.E."}]}, "ref-sourcetitle": "Infect Control Hosp Epidemiol"}}, {"ref-fulltext": "Hsueh PR, Teng LJ, Chen CY, Chen WH, Ho SW, Luh KT. 2002. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 8:827-832. http://dx.doi.org/10.3201/eid0808.020014.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.3201/eid0808.020014", "@type": "email"}}, "ref-title": {"ref-titletext": "Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan"}, "refd-itemidlist": {"itemid": {"$": "0036686040", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "827", "@last": "832"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.R.", "@_fa": "true", "ce:surname": "Hsueh", "ce:indexed-name": "Hsueh P.R."}, {"@seq": "2", "ce:initials": "L.J.", "@_fa": "true", "ce:surname": "Teng", "ce:indexed-name": "Teng L.J."}, {"@seq": "3", "ce:initials": "C.Y.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen C.Y."}, {"@seq": "4", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen W.H."}, {"@seq": "5", "ce:initials": "S.W.", "@_fa": "true", "ce:surname": "Ho", "ce:indexed-name": "Ho S.W."}, {"@seq": "6", "ce:initials": "K.T.", "@_fa": "true", "ce:surname": "Luh", "ce:indexed-name": "Luh K.T."}]}, "ref-sourcetitle": "Emerg Infect Dis"}}, {"ref-fulltext": "Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. 2004. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 48:1586-1592. http://dx.doi.org/10.1128/AAC.48.5.1586-1592.2004.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1128/AAC.48.5.1586-1592.2004", "@type": "email"}}, "ref-title": {"ref-titletext": "In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains"}, "refd-itemidlist": {"itemid": {"$": "2142758673", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48"}, "pagerange": {"@first": "1586", "@last": "1592"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.G.", "@_fa": "true", "ce:surname": "Higgins", "ce:indexed-name": "Higgins P.G."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Wisplinghoff", "ce:indexed-name": "Wisplinghoff H."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Stefanik", "ce:indexed-name": "Stefanik D."}, {"@seq": "4", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Seifert", "ce:indexed-name": "Seifert H."}]}, "ref-sourcetitle": "Antimicrob Agents Chemother"}}, {"ref-fulltext": "Williams JD. 1997. Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin Infect Dis 24:494-497. http://dx.doi.org/10.1093/clinids/24.3.494.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1093/clinids/24.3.494", "@type": "email"}}, "ref-title": {"ref-titletext": "Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone"}, "refd-itemidlist": {"itemid": {"$": "0031024410", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "494", "@last": "497"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "Williams", "ce:indexed-name": "Williams J.D."}]}, "ref-sourcetitle": "Clin Infect Dis"}}, {"ref-fulltext": "Rodr\u00edguez-Hern\u00e1ndez MJ, Cuberos L, Pichardo C, Caballero FJ, Moreno I, Jim\u00e9nez-Mej\u00edas ME, Garc\u00eda-Curiel A, Pach\u00f3n J. 2001. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains. J Antimicrob Chemother 47:479-482. http://dx.doi.org/10.1093/jac/47.4.479.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1093/jac/47.4.479", "@type": "email"}}, "ref-title": {"ref-titletext": "Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains"}, "refd-itemidlist": {"itemid": {"$": "0035044979", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "47"}, "pagerange": {"@first": "479", "@last": "482"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Rodr\u00edguez-Hern\u00e1ndez", "ce:indexed-name": "Rodriguez-Hernandez M.J."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Cuberos", "ce:indexed-name": "Cuberos L."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pichardo", "ce:indexed-name": "Pichardo C."}, {"@seq": "4", "ce:initials": "F.J.", "@_fa": "true", "ce:surname": "Caballero", "ce:indexed-name": "Caballero F.J."}, {"@seq": "5", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Moreno", "ce:indexed-name": "Moreno I."}, {"@seq": "6", "ce:initials": "M.E.", "@_fa": "true", "ce:surname": "Jim\u00e9nez-Mej\u00edas", "ce:indexed-name": "Jimenez-Mejias M.E."}, {"@seq": "7", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Garc\u00eda-Curiel", "ce:indexed-name": "Garcia-Curiel A."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Pach\u00f3n", "ce:indexed-name": "Pachon J."}]}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "Wildfeuer A, R\u00e4der K. 1996. Stability of \u03b2-lactamase inhibitors and \u03b2-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin. Int J Antimicrob Agents 6:S31-S34. http://dx.doi.org/10.1016/0924-8579(95)00058-5.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/0924-8579(95)00058-5", "@type": "email"}}, "ref-title": {"ref-titletext": "Stability of \u03b2-lactamase inhibitors and \u03b2-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: A comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin"}, "refd-itemidlist": {"itemid": {"$": "4244102409", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "S31", "@last": "S34"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Wildfeuer", "ce:indexed-name": "Wildfeuer A."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "R\u00e4der", "ce:indexed-name": "Rader K."}]}, "ref-sourcetitle": "Int J Antimicrob Agents"}}, {"ref-fulltext": "Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, Daniel De Backer Layeux B, Wallemacq P, Vincent JL, Jacobs F. 2010. Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 14:R126. http://dx.doi.org/10.1186/cc9091.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1186/cc9091", "@type": "email"}}, "ref-title": {"ref-titletext": "Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock"}, "refd-itemidlist": {"itemid": {"$": "77954078062", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "R126"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.S.", "@_fa": "true", "ce:surname": "Taccone", "ce:indexed-name": "Taccone F.S."}, {"@seq": "2", "ce:initials": "P.F.", "@_fa": "true", "ce:surname": "Laterre", "ce:indexed-name": "Laterre P.F."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Dugernier", "ce:indexed-name": "Dugernier T."}, {"@seq": "4", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Spapen", "ce:indexed-name": "Spapen H."}, {"@seq": "5", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Delattre", "ce:indexed-name": "Delattre I."}, {"@seq": "6", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Wittebole", "ce:indexed-name": "Wittebole X."}, {"@seq": "7", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Daniel De Backer Layeux", "ce:indexed-name": "Daniel De Backer Layeux B."}, {"@seq": "8", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Wallemacq", "ce:indexed-name": "Wallemacq P."}, {"@seq": "9", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Vincent", "ce:indexed-name": "Vincent J.L."}, {"@seq": "10", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Jacobs", "ce:indexed-name": "Jacobs F."}]}, "ref-sourcetitle": "Crit Care"}}, {"ref-fulltext": "Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA. 2012. Subtherapeutic initial \u03b2-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30-39. http://dx.doi.org/10.1378/chest.11-1671.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1378/chest.11-1671", "@type": "email"}}, "ref-title": {"ref-titletext": "Subtherapeutic initial \u03b2-lactam concentrations in select critically ill patients: Association between augmented renal clearance and low trough drug concentrations"}, "refd-itemidlist": {"itemid": {"$": "84863807810", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "142"}, "pagerange": {"@first": "30", "@last": "39"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Udy", "ce:indexed-name": "Udy A.A."}, {"@seq": "2", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Varghese", "ce:indexed-name": "Varghese J.M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Altukroni", "ce:indexed-name": "Altukroni M."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Briscoe", "ce:indexed-name": "Briscoe S."}, {"@seq": "5", "ce:initials": "B.C.", "@_fa": "true", "ce:surname": "McWhinney", "ce:indexed-name": "McWhinney B.C."}, {"@seq": "6", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Ungerer", "ce:indexed-name": "Ungerer J.P."}, {"@seq": "7", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lipman", "ce:indexed-name": "Lipman J."}, {"@seq": "8", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Roberts", "ce:indexed-name": "Roberts J.A."}]}, "ref-sourcetitle": "Chest"}}, {"ref-fulltext": "Yokoyama Y, Matsumoto K, Ikawa K, Watanabe E, Morikawa N, Takeda Y. 2015. Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: dosing considerations for Acinetobacter baumannii infections. J Infect Chemother 21:284-289. http://dx.doi.org/10.1016/j.jiac.2014.12.005.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/j.jiac.2014.12.005", "@type": "email"}}, "ref-title": {"ref-titletext": "Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections"}, "refd-itemidlist": {"itemid": {"$": "84930378566", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21"}, "pagerange": {"@first": "284", "@last": "289"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yokoyama", "ce:indexed-name": "Yokoyama Y."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Matsumoto", "ce:indexed-name": "Matsumoto K."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ikawa", "ce:indexed-name": "Ikawa K."}, {"@seq": "4", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe E."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Morikawa", "ce:indexed-name": "Morikawa N."}, {"@seq": "6", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Takeda", "ce:indexed-name": "Takeda Y."}]}, "ref-sourcetitle": "J Infect Chemother"}}, {"ref-fulltext": "Munford RS, Suffredini AF. 2010. Sepsis, severe sepsis, and septic shock, p 987-1010. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th ed. Churchill Livingstone Elsevier, Philadelphia, PA.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Sepsis, severe sepsis, and septic shock"}, "refd-itemidlist": {"itemid": {"$": "77954225399", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "987", "@last": "1010"}}, "ref-text": "Mandell GL, Bennett JE, Dolin R (ed), 7th ed. Churchill Livingstone Elsevier, Philadelphia, PA", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.S.", "@_fa": "true", "ce:surname": "Munford", "ce:indexed-name": "Munford R.S."}, {"@seq": "2", "ce:initials": "A.F.", "@_fa": "true", "ce:surname": "Suffredini", "ce:indexed-name": "Suffredini A.F."}]}, "ref-sourcetitle": "Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases"}}, {"ref-fulltext": "Abu-Shandi KH. 2009. Quick bioanalytical method of quantification and validation of sulbactam in plasma using high performance liquid chromatography. Cent Eur J Chem 7:354-361. http://dx.doi.org/10.2478/s11532-009-0024-0.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.2478/s11532-009-0024-0", "@type": "email"}}, "ref-title": {"ref-titletext": "Quick bioanalytical method of quantification and validation of sulbactam in plasma using high performance liquid chromatography"}, "refd-itemidlist": {"itemid": {"$": "67649865561", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "354", "@last": "361"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.H.", "@_fa": "true", "ce:surname": "Abu-Shandi", "ce:indexed-name": "Abu-Shandi K.H."}]}, "ref-sourcetitle": "Cent Eur J Chem"}}, {"ref-fulltext": "Boeckmann AJ, Sheiner LB, Beal SL. 2013. NONMEM users guide - part V. Introductory guide. ICON Development Solutions, Hanover, MD.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "refd-itemidlist": {"itemid": {"$": "84963815874", "@idtype": "SGR"}}, "ref-text": "ICON Development Solutions, Hanover, MD", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Boeckmann", "ce:indexed-name": "Boeckmann A.J."}, {"@seq": "2", "ce:initials": "L.B.", "@_fa": "true", "ce:surname": "Sheiner", "ce:indexed-name": "Sheiner L.B."}, {"@seq": "3", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Beal", "ce:indexed-name": "Beal S.L."}]}, "ref-sourcetitle": "NONMEM Users Guide - Part V. Introductory Guide"}}, {"ref-fulltext": "Mould DR. 2007. Defining covariate distribution models for clinical trial simulation, p 31-35. In Kimko HC, Duffull SB (ed), Simulation for designing clinical trials: a pharmacokinetic-pharmacodynamic modeling perspective, vol 127. CRC Press, Boca Raton, FL.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Defining covariate distribution models for clinical trial simulation"}, "refd-itemidlist": {"itemid": {"$": "84889425904", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "127"}, "pagerange": {"@first": "31", "@last": "35"}}, "ref-text": "Kimko HC, Duffull SB (ed), CRC Press, Boca Raton, FL", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.R.", "@_fa": "true", "ce:surname": "Mould", "ce:indexed-name": "Mould D.R."}]}, "ref-sourcetitle": "Simulation for Designing Clinical Trials: A Pharmacokinetic-pharmacodynamic Modeling Perspective"}}, {"ref-fulltext": "Wylie CR, Barrett LC. 1982. Advanced engineering mathematics, 5th ed. McGraw-Hill, Auckland, New Zealand.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "1982"}, "refd-itemidlist": {"itemid": {"$": "0003921177", "@idtype": "SGR"}}, "ref-text": "5th ed. McGraw-Hill, Auckland, New Zealand", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.R.", "@_fa": "true", "ce:surname": "Wylie", "ce:indexed-name": "Wylie C.R."}, {"@seq": "2", "ce:initials": "L.C.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett L.C."}]}, "ref-sourcetitle": "Advanced Engineering Mathematics"}}, {"ref-fulltext": "Taccone FS, Hites M, Beumier M, Scolletta S, Jacobs F. 2011. Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock. Curr Infect Dis Rep 13:406-415. http://dx.doi.org/10.1007/s11908-011-0203-y.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1007/s11908-011-0203-y", "@type": "email"}}, "ref-title": {"ref-titletext": "Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock"}, "refd-itemidlist": {"itemid": {"$": "80052590359", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "406", "@last": "415"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.S.", "@_fa": "true", "ce:surname": "Taccone", "ce:indexed-name": "Taccone F.S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Hites", "ce:indexed-name": "Hites M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Beumier", "ce:indexed-name": "Beumier M."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Scolletta", "ce:indexed-name": "Scolletta S."}, {"@seq": "5", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Jacobs", "ce:indexed-name": "Jacobs F."}]}, "ref-sourcetitle": "Curr Infect Dis Rep"}}, {"ref-fulltext": "Varghese JM, Roberts JA, Lipman J. 2011. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 27:19-34. http://dx.doi.org/10.1016/j.ccc.2010.09.006.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/j.ccc.2010.09.006", "@type": "email"}}, "ref-title": {"ref-titletext": "Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock"}, "refd-itemidlist": {"itemid": {"$": "78649935284", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "27"}, "pagerange": {"@first": "19", "@last": "34"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Varghese", "ce:indexed-name": "Varghese J.M."}, {"@seq": "2", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Roberts", "ce:indexed-name": "Roberts J.A."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lipman", "ce:indexed-name": "Lipman J."}]}, "ref-sourcetitle": "Crit Care Clin"}}, {"ref-fulltext": "Soto E, Shoji S, Muto C, Tomono Y, Marshall S. 2014. Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment. Br J Clin Pharmacol 77:509-521. http://dx.doi.org/10.1111/bcp.12232.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1111/bcp.12232", "@type": "email"}}, "ref-title": {"ref-titletext": "Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: Evaluation of the impact of renal impairment"}, "refd-itemidlist": {"itemid": {"$": "84894471385", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "77"}, "pagerange": {"@first": "509", "@last": "521"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Soto", "ce:indexed-name": "Soto E."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Shoji", "ce:indexed-name": "Shoji S."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Muto", "ce:indexed-name": "Muto C."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Tomono", "ce:indexed-name": "Tomono Y."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Marshall", "ce:indexed-name": "Marshall S."}]}, "ref-sourcetitle": "Br J Clin Pharmacol"}}, {"ref-fulltext": "Sharma VD, Singla A, Chaudhary M, Taneja M. 2016. Population pharmacokinetics of fixed dose combination of ceftriaxone and sulbactam in healthy and infected subjects. AAPS PharmSciTech 17:1192-1203. http://dx.doi.org/10.1208/s12249-015-0454-2.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1208/s12249-015-0454-2", "@type": "email"}}, "ref-title": {"ref-titletext": "Population pharmacokinetics of fixed dose combination of ceftriaxone and sulbactam in healthy and infected subjects"}, "refd-itemidlist": {"itemid": {"$": "84949486882", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "1192", "@last": "1203"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.D.", "@_fa": "true", "ce:surname": "Sharma", "ce:indexed-name": "Sharma V.D."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Singla", "ce:indexed-name": "Singla A."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Chaudhary", "ce:indexed-name": "Chaudhary M."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Taneja", "ce:indexed-name": "Taneja M."}]}, "ref-sourcetitle": "AAPS PharmSciTech"}}, {"ref-fulltext": "Jaruratanasirikul S, Wongpoowarak W, Aeinlang N, Jullangkoon M. 2013. Pharmacodynamics modeling to optimize dosage regimens of sulbactam. Antimicrob Agent Chemother 57:3441-3444. http://dx.doi.org/10.1128/AAC.00342-13.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1128/AAC.00342-13", "@type": "email"}}, "ref-title": {"ref-titletext": "Pharmacodynamics modeling to optimize dosage regimens of sulbactam"}, "refd-itemidlist": {"itemid": {"$": "84879014715", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "57"}, "pagerange": {"@first": "3441", "@last": "3444"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Wongpoowarak", "ce:indexed-name": "Wongpoowarak W."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Aeinlang", "ce:indexed-name": "Aeinlang N."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Jullangkoon", "ce:indexed-name": "Jullangkoon M."}]}, "ref-sourcetitle": "Antimicrob Agent Chemother"}}, {"ref-fulltext": "Rolinson GN, Sutherland R. 1965. The binding of antibiotics to serum proteins. Br J Pharmacol 25:638-650.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "1965"}, "ref-title": {"ref-titletext": "The binding of antibiotics to serum proteins"}, "refd-itemidlist": {"itemid": {"$": "0013829841", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "25"}, "pagerange": {"@first": "638", "@last": "650"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.N.", "@_fa": "true", "ce:surname": "Rolinson", "ce:indexed-name": "Rolinson G.N."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Sutherland", "ce:indexed-name": "Sutherland R."}]}, "ref-sourcetitle": "Br J Pharmacol"}}, {"ref-fulltext": "Craig WA. 1995. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 22:89-96. http://dx.doi.org/10.1016/0732-8893(95)00053-D.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "1995"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/0732-8893(95)00053-D", "@type": "email"}}, "ref-title": {"ref-titletext": "Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins"}, "refd-itemidlist": {"itemid": {"$": "0029097440", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "89", "@last": "96"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.A.", "@_fa": "true", "ce:surname": "Craig", "ce:indexed-name": "Craig W.A."}]}, "ref-sourcetitle": "Diagn Microbiol Infect Dis"}}, {"ref-fulltext": "Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig WA. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 158:831-847. http://dx.doi.org/10.1093/infdis/158.4.831.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1093/infdis/158.4.831", "@type": "email"}}, "ref-title": {"ref-titletext": "Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model"}, "refd-itemidlist": {"itemid": {"$": "0023697158", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "158"}, "pagerange": {"@first": "831", "@last": "847"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Vogelman", "ce:indexed-name": "Vogelman B."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gudmundsson", "ce:indexed-name": "Gudmundsson S."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Leggett", "ce:indexed-name": "Leggett J."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Turnidge", "ce:indexed-name": "Turnidge J."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ebert", "ce:indexed-name": "Ebert S."}, {"@seq": "6", "ce:initials": "W.A.", "@_fa": "true", "ce:surname": "Craig", "ce:indexed-name": "Craig W.A."}]}, "ref-sourcetitle": "J Infect Dis"}}, {"ref-fulltext": "Yokoyama Y, Matsumoto K, Ikawa K, Watanabe E, Shigemi A, Umezaki Y, Nakamura K, Ueno K, Morikawa N, Takeda Y. 2014. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models. Int J Antimicrob Agents 43:547-552. http://dx.doi.org/10.1016/j.ijantimicag.2014.02.012.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/j.ijantimicag.2014.02.012", "@type": "email"}}, "ref-title": {"ref-titletext": "Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models"}, "refd-itemidlist": {"itemid": {"$": "84902113531", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "43"}, "pagerange": {"@first": "547", "@last": "552"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yokoyama", "ce:indexed-name": "Yokoyama Y."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Matsumoto", "ce:indexed-name": "Matsumoto K."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ikawa", "ce:indexed-name": "Ikawa K."}, {"@seq": "4", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe E."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Shigemi", "ce:indexed-name": "Shigemi A."}, {"@seq": "6", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Umezaki", "ce:indexed-name": "Umezaki Y."}, {"@seq": "7", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Nakamura", "ce:indexed-name": "Nakamura K."}, {"@seq": "8", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ueno", "ce:indexed-name": "Ueno K."}, {"@seq": "9", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Morikawa", "ce:indexed-name": "Morikawa N."}, {"@seq": "10", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Takeda", "ce:indexed-name": "Takeda Y."}]}, "ref-sourcetitle": "Int J Antimicrob Agents"}}, {"ref-fulltext": "Betrosian AP, Frantzeskaki F, Xanthaki A, Georgiadis G. 2007. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scand J Infect Dis 39:38-43. http://dx.doi.org/10.1080/00365540600951184.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1080/00365540600951184", "@type": "email"}}, "ref-title": {"ref-titletext": "High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii"}, "refd-itemidlist": {"itemid": {"$": "33847152542", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "39"}, "pagerange": {"@first": "38", "@last": "43"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.P.", "@_fa": "true", "ce:surname": "Betrosian", "ce:indexed-name": "Betrosian A.P."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Frantzeskaki", "ce:indexed-name": "Frantzeskaki F."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Xanthaki", "ce:indexed-name": "Xanthaki A."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Georgiadis", "ce:indexed-name": "Georgiadis G."}]}, "ref-sourcetitle": "Scand J Infect Dis"}}, {"ref-fulltext": "Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE. 2008. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. J Infect 56:432-436. http://dx.doi.org/10.1016/j.jinf.2008.04.002.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/j.jinf.2008.04.002", "@type": "email"}}, "ref-title": {"ref-titletext": "Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia"}, "refd-itemidlist": {"itemid": {"$": "46549084905", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "432", "@last": "436"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.P.", "@_fa": "true", "ce:surname": "Betrosian", "ce:indexed-name": "Betrosian A.P."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Frantzeskaki", "ce:indexed-name": "Frantzeskaki F."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Xanthaki", "ce:indexed-name": "Xanthaki A."}, {"@seq": "4", "ce:initials": "E.E.", "@_fa": "true", "ce:surname": "Douzinas", "ce:indexed-name": "Douzinas E.E."}]}, "ref-sourcetitle": "J Infect"}}, {"ref-fulltext": "Jaruratanasirikul S, Thengyai S, Wongpoowarak W, Wattanavijitkul T, Tangkitwanitjaroen K, Sukarnjanaset W, Jullangkoon M, Samaeng M. 2015. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive-care units. Antimicrob Agents Chemother 59:2995-3001. http://dx.doi.org/10.1128/AAC.04166-14.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1128/AAC.04166-14", "@type": "email"}}, "ref-title": {"ref-titletext": "Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive-care units"}, "refd-itemidlist": {"itemid": {"$": "84929629126", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "59"}, "pagerange": {"@first": "2995", "@last": "3001"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Thengyai", "ce:indexed-name": "Thengyai S."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Wongpoowarak", "ce:indexed-name": "Wongpoowarak W."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Wattanavijitkul", "ce:indexed-name": "Wattanavijitkul T."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Tangkitwanitjaroen", "ce:indexed-name": "Tangkitwanitjaroen K."}, {"@seq": "6", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Sukarnjanaset", "ce:indexed-name": "Sukarnjanaset W."}, {"@seq": "7", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Jullangkoon", "ce:indexed-name": "Jullangkoon M."}, {"@seq": "8", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Samaeng", "ce:indexed-name": "Samaeng M."}]}, "ref-sourcetitle": "Antimicrob Agents Chemother"}}, {"ref-fulltext": "Jaruratanasirikul S, Wongpoowarak W, Kositpantawong N, Aeinlang N, Jullangkoon M. 2012. Pharmacodynamics of doripenem in critically ill patients with ventilator-associated gram-negative bacilli pneumonia. Int J Antimicrob Agents 40:434-439. http://dx.doi.org/10.1016/j.ijantimicag.2012.07.014.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-website": {"ce:e-address": {"$": "http://dx.doi.org/10.1016/j.ijantimicag.2012.07.014", "@type": "email"}}, "ref-title": {"ref-titletext": "Pharmacodynamics of doripenem in critically ill patients with ventilator-associated gram-negative bacilli pneumonia"}, "refd-itemidlist": {"itemid": {"$": "84867405492", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "434", "@last": "439"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Wongpoowarak", "ce:indexed-name": "Wongpoowarak W."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kositpantawong", "ce:indexed-name": "Kositpantawong N."}, {"@seq": "4", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Aeinlang", "ce:indexed-name": "Aeinlang N."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Jullangkoon", "ce:indexed-name": "Jullangkoon M."}]}, "ref-sourcetitle": "Int J Antimicrob Agents"}}]}}}}, "affiliation": [{"affiliation-city": "Hatyai", "@id": "60006314", "affilname": "Prince of Songkla University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84996567175", "dc:description": "Sulbactam is being considered as an alternative concomitant medication with other effective antibiotics for the treatment of multidrug-resistant (MDR) Acinetobacter baumannii infections. Pathophysiological changes in critically ill patients with severe sepsis, resulting in altered pharmacokinetic (PK) patterns for antibiotics, are important factors in determining therapeutic success. The aims of this study were (i) to examine the population PK parameters and (ii) to assess the probability of target attainment (PTA) for sulbactam in patients with severe sepsis caused by A. baumannii. PK studies were carried out following administration of 2 g of sulbactam every 12 h on the 4th day of drug administration in 27 patients, and a Monte Carlo simulation was performed to determine the PTA of achieving 40% exposure time during which the plasma drug concentration remained above the MIC (T>MIC) and 60% T>MIC. The central and peripheral volumes of distribution were 14.56 and 9.55 liters, respectively, and total clearances of sulbactam were 2.26 liters/h and 7.64 liters/h in patients aged >65 years and \u226465 years, respectively. The high PTAs (\u226590%) for targets of 40% T>MIC and 60% T>MIC with a MIC of 4 \u03bcg/ml were observed when sulbactam was administered by a 4-h infusion of 1 g every 12 h and 1 g every 8 h, respectively. Sulbactam would be an alternative antibiotic option to coadminister with colistin for the treatment of infections caused by MDR A. baumannii. However, for pathogens with MICs of >4 \u03bcg/ml, higher dosage regimens of sulbactam are required.", "pubmed-id": "27671056", "prism:coverDate": "2016-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84996567175", "dc:creator": {"author": [{"ce:given-name": "Sutep", "preferred-name": {"ce:given-name": "Sutep", "ce:initials": "S.", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60006314", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"}, "ce:surname": "Jaruratanasirikul", "@auid": "57208302098", "author-url": "https://api.elsevier.com/content/author/author_id/57208302098", "ce:indexed-name": "Jaruratanasirikul S."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84996567175"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84996567175&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84996567175&origin=inward"}], "source-id": "19615", "citedby-count": "27", "prism:volume": "60", "subtype": "ar", "dc:title": "Population pharmacokinetics and pharmacodynamics modeling to optimize dosage regimens of sulbactam in critically ill patients with severe sepsis caused by Acinetobacter baumannii", "openaccess": "1", "prism:issn": "10986596 00664804", "publishercopyright": "Copyright \u00a9 2016, American Society for Microbiology. All Rights Reserved.", "prism:issueIdentifier": "12", "subtypeDescription": "Article", "prism:publicationName": "Antimicrobial Agents and Chemotherapy", "prism:pageRange": "7236-7244", "prism:endingPage": "7244", "openaccessFlag": "true", "prism:doi": "10.1128/AAC.01669-16", "prism:startingPage": "7236", "dc:identifier": "SCOPUS_ID:84996567175", "dc:publisher": "American Society for MicrobiologyJournals@asmusa.org"}, "idxterms": {"mainterm": [{"$": "Acinetobacter baumannii", "@weight": "b", "@candidate": "n"}, {"$": "Acinetobacter Infections", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Aged, 80 and over", "@weight": "b", "@candidate": "n"}, {"$": "Anti-Bacterial Agents", "@weight": "b", "@candidate": "n"}, {"$": "Colistin", "@weight": "b", "@candidate": "n"}, {"$": "Critical Illness", "@weight": "b", "@candidate": "n"}, {"$": "Drug Resistance, Multiple, Bacterial", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Microbial Sensitivity Tests", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Sepsis", "@weight": "b", "@candidate": "n"}, {"$": "Sulbactam", "@weight": "a", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": null, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Infectious Diseases", "@code": "2725", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Sutep", "preferred-name": {"ce:given-name": "Sutep", "ce:initials": "S.", "ce:surname": "Jaruratanasirikul", "ce:indexed-name": "Jaruratanasirikul S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60006314", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"}, "ce:surname": "Jaruratanasirikul", "@auid": "57208302098", "author-url": "https://api.elsevier.com/content/author/author_id/57208302098", "ce:indexed-name": "Jaruratanasirikul S."}, {"ce:given-name": "Wibul", "preferred-name": {"ce:given-name": "Wibul", "ce:initials": "W.", "ce:surname": "Wongpoowarak", "ce:indexed-name": "Wongpoowarak W."}, "@seq": "2", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60006314", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"}, "ce:surname": "Wongpoowarak", "@auid": "6603470219", "author-url": "https://api.elsevier.com/content/author/author_id/6603470219", "ce:indexed-name": "Wongpoowarak W."}, {"ce:given-name": "Thitima", "preferred-name": {"ce:given-name": "Thitima", "ce:initials": "T.", "ce:surname": "Wattanavijitkul", "ce:indexed-name": "Wattanavijitkul T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Wattanavijitkul", "@auid": "56422407400", "author-url": "https://api.elsevier.com/content/author/author_id/56422407400", "ce:indexed-name": "Wattanavijitkul T."}, {"ce:given-name": "Waroonrat", "preferred-name": {"ce:given-name": "Waroonrat", "ce:initials": "W.", "ce:surname": "Sukarnjanaset", "ce:indexed-name": "Sukarnjanaset W."}, "@seq": "4", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sukarnjanaset", "@auid": "56652241200", "author-url": "https://api.elsevier.com/content/author/author_id/56652241200", "ce:indexed-name": "Sukarnjanaset W."}, {"ce:given-name": "Maseetoh", "preferred-name": {"ce:given-name": "Maseetoh", "ce:initials": "M.", "ce:surname": "Samaeng", "ce:indexed-name": "Samaeng M."}, "@seq": "5", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60006314", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"}, "ce:surname": "Samaeng", "@auid": "37064896200", "author-url": "https://api.elsevier.com/content/author/author_id/37064896200", "ce:indexed-name": "Samaeng M."}, {"ce:given-name": "Monchana", "preferred-name": {"ce:given-name": "Monchana", "ce:initials": "M.", "ce:surname": "Nawakitrangsan", "ce:indexed-name": "Nawakitrangsan M."}, "@seq": "6", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60006314", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"}, "ce:surname": "Nawakitrangsan", "@auid": "57191380618", "author-url": "https://api.elsevier.com/content/author/author_id/57191380618", "ce:indexed-name": "Nawakitrangsan M."}, {"ce:given-name": "Natnicha", "preferred-name": {"ce:given-name": "Natnicha", "ce:initials": "N.", "ce:surname": "Ingviya", "ce:indexed-name": "Ingviya N."}, "@seq": "7", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60006314", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"}, "ce:surname": "Ingviya", "@auid": "8708620300", "author-url": "https://api.elsevier.com/content/author/author_id/8708620300", "ce:indexed-name": "Ingviya N."}]}}}